Skip to main content

Table 1 Demographic and clinical characteristic of study subjects

From: Association of [1H]-MRS quantified liver fat content with glucose metabolism status

Parameters

nT2DM

(n = 141)

PDM

(n = 48)

NC

(n = 53)

p value

Age (year)

50.8 ± 10.1

49.7 ± 13.0

47.0 ± 8.0

0.078

Gender (female/male)

69/72

23/25

25/28

0.974

BMI (kg/cm2)

26.5 (25.4, 27.7)

25.7 (24.1, 26.8)

23.6 (22.1, 24.6)

0.000

WC (cm)

88.72 ± 9.94

91.87 ± 9.00

83.08 ± 7.81

0.000

HIP (cm)

92.06 ± 8.14

98.63 ± 8.39

95.19 ± 6.96

0.000

WHR

0.95 (0.92, 1.04)

0.90 (0.88, 0.94)

0.86 (0.83, 0.88)

0.000

SBP (mmHg)

135 ± 16

136 ± 16

125 ± 14

0.001

DBP (mmHg)

83 ± 11

83 ± 11

77 ± 10

0.001

Urea Nitrogen (mmol/l)

5.10 ± 1.48

5.09 ± 1.56

4.82 ± 1.18

0.464

Cr (umol/l)

57.97 ± 14.37

59.98 ± 14.20

62.85 ± 13.80

0.101

UA (umol/l)

342.04 ± 63.36

319.25 ± 75.46

294.15 ± 54.47

0.000

TBIL(umol/l)

15.9 (13.2, 21.2)

15.7 (11.5, 20.5)

13.6 (11.3, 16.6)

0.074

DBIL(umol/l)

4.2 (3.3, 5.5)

3.7 (2.7, 5.1)

4.2 (3.0, 5.1)

0.540

IBIL(umol/l)

11.9 (9.6, 16.3)

12.0 (8.4, 15.1)

9.6 (7.9, 12.5)

0.045

ALP (U/l)

76 ± 21

76 ± 21

71 ± 22

0.289

AST (U/l)

20 (16, 28)

24 (18, 29)

19 (16, 24)

0.019

ALT (U/l)

35 (32, 38)

31 (26, 36)

18 (13, 27)

0.000

GGT (U/l)

36 (26, 54)

34 (19, 68)

23 (16, 34)

0.007

LDH (U/l)

166 ± 33

189 ± 38

184 ± 32

0.000

TG (mmol/l)

2.4 ± 0.6

1.9 ± 0.7

1.4 ± 0.6

0.000

TC (mmol/l)

5.4 ± 0.3

4.8 ± 0.2

4.1 ± 0.4

0.000

HDL-C (mmol/l)

1.4 ± 0.3

1.5 ± 0.3

1.6 ± 0.4

0.000

LDL-C (mmol/l)

3.3 ± 0.4

2.9 ± 0.7

2.2 ± 0.2

0.000

VLDL-C (mmol/l)

0.4 (0.3, 0.6)

0.3 (0.2, 0.5)

0.2 (0.1, 0.4)

0.003

ApoB (g/l)

0.9 (0.7, 1.1)

0.9 (0.7, 1.0)

0.9 (0.8, 1.0)

0.403

ApoA1 (g/l)

1.1 ± 0.2

1.2 ± 0.2

1.2 ± 0.2

0.000

FPG (mmol/l)

7.44 ± 1.07

5.54 ± 0.65

4.84 ± 0.62

0.000

2hPG (mmol/l)

16.90 (14.00, 17.88)

8.93 (8.05, 9.75)

6.05 (5.34, 6.71)

0.000

Fasting Insulin (mU/l)

6.31 (5.24, 8.47)

7.77 (6.05, 8.70)

6.63 (5.54, 8.26)

0.021

HOMA-IR

2.20 (1.73, 2.78)

1.82 (1.45, 2.22)

1.44 (1.19, 1.86)

0.000

HOMA-β

32.89 (24.32, 45.60)

81.09 (59.16, 109.50)

117.11 (74.55, 158.77)

0.000

Matsuda ISI

93.38 ± 38.31

78.76 ± 24.14

114.64 ± 44.28

0.000

  1. ApoA1 Apolipoprotein A1, ApoB Apolipoprotein B, ALP alkaline phosphatase, AST aspartate aminotransferase, ALT alanine transaminase, BMI body mass index, Cr creatine, DBIL direct bilirubin, DBP diastolic blood pressure, FPG fasting plasma glucose, GGT γ-glutamyltransferase, HOMA-IR homeostatic model assessment of insulin resistance, HOMA-β homeostatic model assessment for β-cell function, HDL-C high-density lipoprotein cholesterol, IBIL indirect bilirubin, LDH lactate dehydrogenase, LDL-C low-density lipoprotein cholesterol, nT2DM newly diagnosed type 2 diabetes mellitus, NC normal control, PDM prediabetes mellitus, SBP systolic blood pressure, TC total cholesterol, TG triglycerides, TBIL total bilirubin, UA uric acid, VLDL-C very low-density lipoprotein cholesterol, WC waist circumference, WHR waist-to-hip ratio